Literature DB >> 12811430

Estimating domain orientation of two human antibody IgG4 chimeras by crystallohydrodynamics.

Emma Longman1, Katja Kreusel, Saul B Tendler, Immo Fiebrig, Kevin King, John Adair, Paul O'Shea, Alvaro Ortega, Jose Garcia de la Torre, Stephen E Harding.   

Abstract

A modified crystallohydrodynamic approach introduced in 2001 is applied to two human IgG4 constructs from mouse IgG1. The constructs were point mutants of the chimeric antibody molecule cB72.3(gamma4): cB72.3(gamma4A), devoid of inter-chain disulfide bridging, and cB72.3(gamma4P), which has full inter-chain bridging. As before, the known crystallographic structures for the Fab and Fc domains were combined with the measured translational frictional ratios to obtain an estimate for the apparent time-averaged hydration of the domains and hence for that of the intact molecule. The original approach was modified with the hydrated dimensions of the domains being applied, rather than the anhydrous crystallographic dimensions, for assessing the inter-domain orientations using the algorithms HYDROSUB and SOLPRO. Both chimeric IgG4 molecules were found to have open, rather than compact, structures, in agreement with the previous study on wild-type human IgG4. The insertion of a frictionless connector between the domains was necessary, however, for representing the cB72.3(gamma4A) chimera. It therefore appears that the inter-chain disulfide bonds act as physical constraints in the cB72.3(gamma4P) chimera, forcing the antibody domains together and producing a less elongated structure than that of cB72.3(gamma4A). The open structures produced for the two IgG4 chimeras showed similarity to those structures identified for murine IgG1 and IgG2a molecules through X-ray crystallography.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12811430     DOI: 10.1007/s00249-003-0314-y

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  14 in total

1.  Novel size-independent modeling of the dilute solution conformation of the immunoglobulin IgG Fab' domain using SOLPRO and ELLIPS.

Authors:  B Carrasco; J G de la Torre; O Byron; D King; C Walters; S Jones; S E Harding
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

2.  Hydrodynamic properties of rigid particles: comparison of different modeling and computational procedures.

Authors:  B Carrasco; J García de la Torre
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  Hydrodynamic study of flexibility in immunoglobulin IgG1 using Brownian dynamics and the Monte Carlo simulations of a simple model.

Authors:  F G Díaz; A Iniesta; J García de la Torre
Journal:  Biopolymers       Date:  1990       Impact factor: 2.505

4.  A model for the solution conformation of rat IgE.

Authors:  K G Davis; M Glennie; S E Harding; D R Burton
Journal:  Biochem Soc Trans       Date:  1990-10       Impact factor: 5.407

5.  SOLPRO: theory and computer program for the prediction of SOLution PROperties of rigid macromolecules and bioparticles.

Authors:  J García de la Torre; B Carrasco; S E Harding
Journal:  Eur Biophys J       Date:  1997       Impact factor: 1.733

6.  The ELLIPS suite of macromolecular conformation algorithms.

Authors:  S E Harding; J C Horton; H Cölfen
Journal:  Eur Biophys J       Date:  1997       Impact factor: 1.733

7.  Refined structure of an intact IgG2a monoclonal antibody.

Authors:  L J Harris; S B Larson; K W Hasel; A McPherson
Journal:  Biochemistry       Date:  1997-02-18       Impact factor: 3.162

8.  Crystallographic structure of an intact IgG1 monoclonal antibody.

Authors:  L J Harris; E Skaletsky; A McPherson
Journal:  J Mol Biol       Date:  1998-02-06       Impact factor: 5.469

9.  Three-dimensional structure of the Mcg IgG1 immunoglobulin.

Authors:  S S Rajan; K R Ely; E E Abola; M K Wood; P M Colman; R J Athay; A B Edmundson
Journal:  Mol Immunol       Date:  1983-07       Impact factor: 4.407

10.  A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody.

Authors:  S Angal; D J King; M W Bodmer; A Turner; A D Lawson; G Roberts; B Pedley; J R Adair
Journal:  Mol Immunol       Date:  1993-01       Impact factor: 4.407

View more
  6 in total

1.  Construction, MD simulation, and hydrodynamic validation of an all-atom model of a monoclonal IgG antibody.

Authors:  J Paul Brandt; Thomas W Patapoff; Sergio R Aragon
Journal:  Biophys J       Date:  2010-08-04       Impact factor: 4.033

2.  Multi-scale calculation and global-fit analysis of hydrodynamic properties of biological macromolecules: determination of the overall conformation of antibody IgG molecules.

Authors:  D Amorós; A Ortega; S E Harding; J García de la Torre
Journal:  Eur Biophys J       Date:  2008-12-18       Impact factor: 1.733

3.  Hydrodynamic modelling of protein conformation in solution: ELLIPS and HYDRO.

Authors:  José García de la Torre; Stephen E Harding
Journal:  Biophys Rev       Date:  2013-02-20

4.  Solution conformation of wild-type and mutant IgG3 and IgG4 immunoglobulins using crystallohydrodynamics: possible implications for complement activation.

Authors:  Yanling Lu; Stephen E Harding; Terje E Michaelsen; Emma Longman; Kenneth G Davis; Alvaro Ortega; J Günter Grossmann; Inger Sandlie; José García de la Torre
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

5.  Crystallohydrodynamics of protein assemblies: Combining sedimentation, viscometry, and x-ray scattering.

Authors:  Yanling Lu; Emma Longman; Kenneth G Davis; Alvaro Ortega; J Günter Grossmann; Terje E Michaelsen; José García de la Torre; Stephen E Harding
Journal:  Biophys J       Date:  2006-06-09       Impact factor: 4.033

6.  The Fab conformations in the solution structure of human immunoglobulin G4 (IgG4) restrict access to its Fc region: implications for functional activity.

Authors:  Lucy E Rayner; Gar Kay Hui; Jayesh Gor; Richard K Heenan; Paul A Dalby; Stephen J Perkins
Journal:  J Biol Chem       Date:  2014-05-29       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.